TEM

Tempus AI, Inc. Class A Common Stock

52.40 USD
-4.23
7.47%
At close Nov 15, 4:00 PM EST
After hours
52.60
+0.20
0.38%
1 day
-7.47%
5 days
-24.91%
1 month
12.37%
3 months
11.02%
6 months
30.19%
Year to date
30.19%
1 year
30.19%
5 years
30.19%
10 years
30.19%
 

About: Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.

Employees: 2,300

0
Funds holding %
of 6,704 funds
0
Analysts bullish %
of 4 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

54% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 28

53% more call options, than puts

Call options by funds: $78.1M | Put options by funds: $51.2M

42% more capital invested

Capital invested by funds: $1.49B [Q2] → $2.11B (+$622M) [Q3]

22% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 18

20% more funds holding in top 10

Funds holding in top 10: 5 [Q2] → 6 (+1) [Q3]

19% more funds holding

Funds holding: 80 [Q2] → 95 (+15) [Q3]

1.54% less ownership

Funds ownership: 26.66% [Q2] → 25.12% (-1.54%) [Q3]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$57
9%
upside
Avg. target
$63
20%
upside
High target
$70
34%
upside

4 analyst ratings

positive
25%
neutral
75%
negative
0%
Piper Sandler
David Westenberg
55% 1-year accuracy
11 / 20 met price target
34%upside
$70
Neutral
Reiterated
12 Nov 2024
Stifel
Daniel Arias
17% 1-year accuracy
3 / 18 met price target
24%upside
$65
Hold
Downgraded
11 Nov 2024
Loop Capital
Mark Schappel
75% 1-year accuracy
12 / 16 met price target
9%upside
$57
Buy
Maintained
15 Oct 2024
B of A Securities
Michael Ryskin
75% 1-year accuracy
3 / 4 met price target
15%upside
$60
Neutral
Downgraded
2 Oct 2024

Financial journalist opinion

Based on 12 articles about TEM published over the past 30 days

Charts implemented using Lightweight Charts™